Figure 2.
Survival curves of patients treated with R-CHOP–based immunochemotherapy. (A) PFS for IPI risk groups. (B) OS for IPI risk groups.
Survival curves of patients treated with R-CHOP–based immunochemotherapy. (A) PFS for IPI risk groups. (B) OS for IPI risk groups.
